| Isotretinoin |
0 |
0.92 |
| COVID-19 |
0 |
0.88 |
| Acne |
0 |
0.86 |
| Rosacea |
0 |
0.82 |
| Pregnancy |
0 |
0.6 |
| Pandemic |
0 |
0.37 |
| Otolaryngology |
0 |
0.25 |
| Telehealth and Telemedicine |
0 |
0.16 |
| Electronic Health Record (EHR) and Healthcare Technology |
0 |
0.1 |
| Health Care Quality, Access, and Evaluation |
0 |
0.09 |
| Revenue and Practice Management |
0 |
0.08 |
| Skin and Soft Tissue Infection |
0 |
0.08 |
| Social Determinants of Health |
0 |
0.08 |
| Adherence |
0 |
0.06 |
| Patient Counseling |
0 |
0.06 |
| Patient Safety |
0 |
0.06 |
| Receptors |
0 |
0.06 |
| Health Insurance Portability and Accountability Act |
0 |
0.05 |
| Health Insurance |
0 |
0.04 |
| Risk Evaluation and Mitigation Strategies (REMS) |
0 |
0.04 |
| Adolescent Medicine |
0 |
0.03 |
| Cardiovascular Risk Management |
0 |
0.03 |
| Contraception |
0 |
0.03 |
| Drug and Treatment Safety |
0 |
0.03 |
| Hand |
0 |
0.03 |
| Hypertriglyceridemia |
0 |
0.03 |
| Insurance |
0 |
0.03 |
| Interprofessional Continuing Education |
0 |
0.03 |
| Lipids Management |
0 |
0.03 |
| Medical Innovations |
0 |
0.03 |
| Nasal Mucosa |
0 |
0.03 |
| Stress |
0 |
0.03 |
| Students |
0 |
0.03 |
| Teledermatology |
0 |
0.03 |
| Young Adult |
0 |
0.03 |